Plain-English translation of NCT07335900 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a minimally invasive heart valve replacement procedure (called TAVI) can reverse damage to the heart muscle in people with severe aortic stenosis — a condition where the aortic valve narrows and restricts blood flow. Researchers will use special imaging scans before and 6 months after the procedure to see if the treatment reduces scarring and helps the heart muscle recover better than medication alone.
When the aortic valve becomes severely narrowed, it puts stress on the heart muscle, causing it to thicken and scar over time. Doctors want to know whether relieving this valve obstruction through the minimally invasive treatment can actually reverse this damage and improve heart function.
You likely qualify if…
You likely don't qualify if…
If you are assigned to the procedure group, you will undergo the minimally invasive valve replacement according to standard care and receive heart medications. If you are in the medication-only group, you will continue taking heart medications. All participants will have special imaging scans at the beginning of the study and again 6 months later to measure changes in heart muscle scarring and function. The study involves about 25 people total and lasts at least 6 months.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
China